Category:
Active Pharmaceutical Ingredients
CAS NO:
1092939-17-7
Standard:
In-house Standards,
Oncology Myeloma
Ruxolitinib is a potent, selective inhibitor of JAK1 and JAK2 kinases used in oncology. Synthesized via advanced organic coupling, its molecular formula is C20H24N6O with CAS No. 958709-29-6.
Strictly monitor hematological parameters due to anemia and thrombocytopenia risks. Store under controlled conditions at 2–8°C in dry, light-resistant environments to maintain stability.